Actively Recruiting
STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance
Led by Thomas Engstrom · Updated on 2026-03-30
2500
Participants Needed
1
Research Sites
513 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of is study is to investigate whether ischemic postconditioning (iPOST) and intravascular ultrasound-guided (IVUS) percutaneous coronary intervention (PCI) improve the clinical outcome of patients with ST-segment elevation myocardial infarction treated with primary PCI.
CONDITIONS
Official Title
STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Acute onset of chest pain with less than 12 hours duration
- STEMI defined by specific ST elevation or new left bundle branch block criteria on ECG
You will not qualify if you...
- Pre-PCI TIMI flow 0 or 1
- Potential pregnancy
- Inability or unwillingness to provide informed consent
- Need for unavoidable thrombectomy
- Spontaneous coronary artery dissection
- Time from symptom onset to primary PCI greater than 12 hours
- Culprit lesion located in bypass graft
- Other unspecified reasons for exclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Heart Center, Rigshospitalet
Copenhagen, Capital Region, Denmark, 2100
Actively Recruiting
Research Team
T
Thomas Engstrøm, MD PhD DSci
CONTACT
J
Jacob Lønborg, MD PhD DMSci
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here